KARL STORZ Receives FDA Clearance for TIPCAM1 Rubina in Select Cardiac Surgical Procedures

Skip to Content News Archives Economy Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeBusiness Wire News ReleasesPMN Press ReleasesThis section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire KARL STORZ Receives FDA Clearance for TIPCAM1 Rubina in Select Cardiac Surgical ProceduresAuthor of the article:Advanced 4K 3D and NIR/ICG visualization technology now available to support minimally invasive cardiac surgical careTHIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountEL SEGUNDO, Calif. — KARL STORZ, a global leader in advanced surgical visualization and integrated operating room solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared expanded indications for the TIPCAM1™ Rubina™ video endoscope for use in selected cardiac surgical procedures.TIPCAM1™ Rubina™ combines 4K visualization, stereoscopic 3D imaging, and near-infrared fluorescence imaging (NIR/ICG) in a single video endoscope, helping surgeons visualize anatomy with enhanced depth perception and clarity during minimally invasive procedures. The system’s Horizon Control technology automatically maintains image orientation as the scope is rotated, supporting visualization consistency and workflow efficiency.This advertisement has not loaded yet, but your article continues below.The expanded indication broadens access to these advanced imaging capabilities for surgeons performing a variety of complex cardiac interventions, including but not limited to mitral valve repair and replacement, tricuspid valve repair, internal mammary artery mobilization for cardiac revascularization, and structural heart interventions such as left atrial appendage closure or occlusion.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try again“Minimally invasive cardiac procedures require exceptional visualization and spatial awareness,” said Fernando Morales, Vice President, Sales & Marketing, Surgical & OR1, KARL STORZ North America. “This expanded indication reinforces our commitment to advancing surgical care by equipping cardiac surgeons with technologies that support confident decision-making, precise tissue handling, and improved visualization of complex anatomy.”TIPCAM1™ Rubina™ is already used across a broad range of minimally invasive procedures, including general surgery, gynecology, urology, colorectal surgery, bariatric surgery, hepatobiliary surgery, and thoracic surgery. The expanded cardiac indication further extends the platform’s applicability across surgical specialties.The TIPCAM1™ Rubina™ is part of the KARL STORZ IMAGE1 S™ platform, a modular visualization ecosystem designed to support a broad range of surgical specialties. The scalable architecture of IMAGE1 S™ enables healthcare facilities to further advance their imaging capabilities while maximizing existing investments in OR technology.KARL STORZ is an innovative leader in endoscopic technology and surgical imaging across virtually all surgical specialties. Its integrated OR solutions enhance collaboration to improve clinical efficiency and outcomes inside the hospital and other sites of care. With subsidiaries around the world, KARL STORZ is a family-owned company based in Germany that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. For more information, visit www.karlstorz.com.View source version on businesswire.com: Media contact: Susan Mancia Marketing Communications KARL STORZ North America 657-385-5285This advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.